CTOs on the Move

Contract Research Organization

www.wcct.com

 
WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special ...
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.wcct.com
  • 5630 Cerritos Ave
    Cypress, CA USA 90630-4721
  • Phone: 714.252.0700

Executives

Name Title Contact Details

Similar Companies

Asterand, plc

Asterand, plc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Asterand, plc is based in Detroit, MI. You can find more information on Asterand, plc at www.asterand.com

Mela Sciences

At MELA Sciences, we design and develop innovative software-driven medical technologies for physician clinical use during the detection of skin cancers at the most curable and cost-effective stages. Our mission is to develop breakthrough medical technologies to improve skin cancer detection and achieve better outcomes for all. We envision a world in which our pioneering innovations will change the way patients think about skin cancer, while providing dermatologists and clinicians with new, effective, non-invasive tools for the earliest detection possible. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.

LandM Healthcare Communications

L&M Healthcare Communications is a Mountainside, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

r3 Health Partners

r3 Health Partners is a Santa Ana, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Amarin Corporation

Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin`s product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Vascepa® (icosapent ethyl) is Amarin`s first FDA approved product and is available in the United States by prescription.